Guo X - Search Results

1

Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

Zhang L, Tang LQ, Chen QY, Liu H, Guo SS, Liu LT, Guo L, Mo HY, Zhao C, Guo X, Cao KJ, Qian CN, Zeng MS, Shao JY, Sun Y, Ma J, Hong MH, Mai HQ. Zhang L, et al. Among authors: guo ss, guo x, guo l. Oncotarget. 2016 Feb 2;7(5):6221-30. doi: 10.18632/oncotarget.6754. Oncotarget. 2016. PMID: 26716900 Free PMC article.

2

Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.

Qian CN, Guo X, Cao B, Kort EJ, Lee CC, Chen J, Wang LM, Mai WY, Min HQ, Hong MH, Vande Woude GF, Resau JH, Teh BT. Qian CN, et al. Among authors: guo x. Cancer Res. 2002 Jan 15;62(2):589-96. Cancer Res. 2002. PMID: 11809714

3

Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses.

Guo X, Lui WO, Qian CN, Chen JD, Gray SG, Rhodes D, Haab B, Stanbridge E, Wang H, Hong MH, Min HQ, Larsson C, Teh BT. Guo X, et al. Int J Oncol. 2002 Dec;21(6):1197-204. Int J Oncol. 2002. PMID: 12429968

4

[Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].

Cao SM, Min HQ, Gao JS, Hong MH, Xiao XB, Zhang CQ, Liu XD, Zhang AL, Guo X. Cao SM, et al. Among authors: guo x. Ai Zheng. 2003 Mar;22(3):302-6. Ai Zheng. 2003. PMID: 12654192 Chinese.

5

[Expression of topoisomerase IIalpha in nasopharyngeal carcinoma and its clinical significance].

Xiang YQ, Min HQ, Hong MH, Cao SM, He JH, Hou JH, Guo X. Xiang YQ, et al. Among authors: guo x. Ai Zheng. 2004 Mar;23(3):322-5. Ai Zheng. 2004. PMID: 15025967 Chinese.

6

[Phase I study of capecitabine with concurrent radiotherapy in early-stage nasopharyngeal carcinoma].

Guo L, Lin HX, Li FY, Li Q, Qiu F, Luo DH, Guo X, Hong MH. Guo L, et al. Among authors: guo x. Zhonghua Zhong Liu Za Zhi. 2004 Apr;26(4):250-3. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312392 Clinical Trial. Chinese.

7

[Clinical value of vascular endothelial growth factor detection in forecasting distant metastasis risk of nasopharyngeal carcinoma].

Guo X, Cao SM, Hong MH, Zhang CQ, Han AJ, Xiang YQ, Hou JH, Min HQ. Guo X, et al. Ai Zheng. 2004 Oct;23(10):1171-5. Ai Zheng. 2004. PMID: 15473929 Chinese.

8

High frequency of common deletion (4981 bp) in mitochondrial DNA in nasopharyngeal carcinoma and its correlation with patient age and clinical stages.

Shao JY, Li YH, Gao HY, Mai HQ, Zhang Y, Guo X, Zeng YX. Shao JY, et al. Among authors: guo x. Cancer Biol Ther. 2004 Dec;3(12):1270-4. doi: 10.4161/cbt.3.12.1243. Epub 2004 Dec 14. Cancer Biol Ther. 2004. PMID: 15477759 Free article.

9

[Correlation of endothelin A receptor expression to prognosis of nasopharyngeal carcinoma].

Mai HQ, Zeng ZY, Zhang HZ, Hou JH, Mo HY, Guo X, Min HQ, Hong MH. Mai HQ, et al. Among authors: guo x. Ai Zheng. 2005 May;24(5):611-5. Ai Zheng. 2005. PMID: 15890108 Chinese.

10

[Impact of pre-radiotherapy hemoglobin level on local control of nasopharyngeal carcinoma].

Mai HQ, Mo HY, Hong MH, Guo X, Deng MQ, Zhang F, Min HQ. Mai HQ, et al. Among authors: guo x. Ai Zheng. 2005 Jun;24(6):727-30. Ai Zheng. 2005. PMID: 15946489 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,556 results

Search Page

Filters